tiprankstipranks
Trending News
More News >
Medicenna Therapeutics Corp (TSE:MDNA)
TSX:MDNA
Canadian Market

Medicenna Therapeutics Corp (MDNA) Income Statement

Compare
229 Followers

Medicenna Therapeutics Corp Income Statement

Last quarter (Q2 2026), Medicenna Therapeutics Corp's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q2, Medicenna Therapeutics Corp's net income was C$-4.88M. See Medicenna Therapeutics Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 23Dec 22Dec 21
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -55.00KC$ -5.00KC$ -5.00KC$ -38.00KC$ -40.00K
Operating Expenses
C$ 21.58MC$ 19.66MC$ 16.30MC$ 22.47MC$ 17.39M
Depreciation and Amortization
C$ 55.00KC$ 5.00KC$ 5.00KC$ 38.00KC$ 40.00K
EBITDA
C$ -12.97MC$ -18.67MC$ -16.30MC$ -22.54MC$ -17.25M
Operating Income
C$ -21.63MC$ -19.66MC$ -21.64MC$ -22.30MC$ -17.19M
Other Income/Expenses
C$ 8.60MC$ -5.80MC$ 7.00MC$ 1.65MC$ 106.00K
Pretax Income
C$ -13.03MC$ -25.47MC$ -10.05MC$ -22.58MC$ -17.29M
Net Income
C$ -11.80MC$ -25.47MC$ 1.55MC$ -22.65MC$ -17.18M
Per Share Metrics
Basic EPS
C$ -0.15C$ -0.37C$ 0.02C$ -0.42C$ -0.35
Diluted EPS
C$ -0.15C$ -0.37C$ 0.02C$ -0.42C$ -0.35
Weighted Average Shares Outstanding
76.67M 69.64M 64.74M 54.29M 49.66M
Weighted Average Shares Outstanding (Diluted)
76.67M 69.64M 64.74M 54.29M 49.66M
Currency in CAD

Medicenna Therapeutics Corp Earnings and Revenue History